查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
2073822

全球半固態製劑契約製造市場規模、佔有率、趨勢和成長分析報告（2026-2034年）

Global Semi-Solid Dosage Contract Manufacturing Market Size, Share, Trends & Growth Analysis Report 2026-2034
出版日期: | 出版商: Value Market Research | 英文 187 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

全球半固態製劑契約製造市場預計將從2025年的238.2億美元成長至2034年的640.6億美元，2026年至2034年的複合年成長率（CAGR）為11.62%。該市場正經歷強勁成長，主要得益於製藥公司將乳膏、軟膏、凝膠、洗劑和外用製劑的生產外包給專業生產合作夥伴的趨勢日益成長。對皮膚科產品、疼痛管理療法和化妝品藥品的需求不斷成長，也促使企業更加依賴契約製造生產商。成本最佳化和縮短產品上市時間也是推動市場成長的重要因素。

為了滿足不斷發展的醫藥標準，契約製造製造商正在投資先進的生產設施、自動化填充系統、品質保證技術和法規遵循。對定製配方和專用局部給藥系統日益成長的需求正在推動整個生產流程的創新。製藥公司與契約製造之間的策略合作正在提高生產的柔軟性和營運效率。

預計未來成長將主要得益於藥品外包業務的增加、生物製藥外用療法的推廣以及對先進製造技術的持續投資。數位化品管系統、自動化和永續生產實踐將提升生產效率。全球對高品質外用藥品的需求不斷成長，將繼續為契約製造製造商創造長期發展機會。

我們的報告經過精心撰寫，旨在提供涵蓋廣泛行業和市場的全面且切實可行的洞察。每份報告都包含幾個關鍵組成部分，旨在幫助您全面了解市場環境：

市場概覽：本節對市場進行了清晰的說明，包括關鍵定義、分類以及當前行業格局的概述。

市場動態：對影響市場成長的主要促進因素、限制因素、機會和挑戰進行詳細評估。這包括技術發展、法律規範和不斷變化的行業趨勢等因素。

市場區隔分析：本部分依據產品類型、應用、最終使用者和地區，將市場系統性地分類為若干關鍵細分市場。本部分揭示了每個細分市場的表現、成長潛力和市場貢獻。

競爭格局：我們對主要市場參與企業進行了詳細評估，包括其市場定位、產品系列、策略舉措和財務表現。這有助於深入了解競爭趨勢和主要參與者所採取的策略。

市場預測：本部分提供基於數據的市場規模和成長模式預測，預測期為指定時期。它綜合考慮了歷史趨勢、當前市場狀況和定量分析，以識別預期的未來趨勢。

區域分析：這包括對主要地理區域的市場表現進行全面檢驗，確定高成長領域和區域趨勢，以更深入地了解每個區域特有的市場機會。

新趨勢與新機會：識別關鍵市場趨勢、技術進步和新興投資機會。本部分重點在於潛在成長領域和未來產業趨勢。

客製化選項：我們提供靈活的報告客製化服務，以滿足您的特定需求。這包括額外的細分、國家/地區分析、競爭對手分析、客製化資料點或針對特定細分市場的洞察，從而更有效地支援策略決策。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

  • 市場譜系展望
  • 滲透率和成長前景分析
  • 價值鏈分析
  • 法律規範
    • 標準與合規性
    • 監管影響分析
  • 市場動態
    • 市場促進因素
    • 市場限制因素
    • 市場機遇
    • 市場挑戰
  • 波特五力分析
  • PESTLE分析

第4章：全球半固態製劑契約製造市場：依類型分類

  • 市場分析、洞察與預測
  • 外用
  • 經皮
  • 口服

第5章 全球半固態製劑契約製造市場：依產品分類

  • 市場分析、洞察與預測
  • 奶油
  • 軟膏
  • 凝膠
  • 洗劑
  • 貼上
  • 其他

第6章：全球半固態製劑契約製造市場：依最終用途分類

  • 市場分析、洞察與預測
  • 製藥公司
  • 藥用化妝品公司
  • 其他

第7章：全球半固態製劑契約製造市場：依公司規模分類

  • 市場分析、洞察與預測
  • 大公司
  • 小型企業
  • 其他

第8章：全球半固態製劑契約製造市場：按地區分類

  • 區域分析
  • 北美市場分析、洞察與預測
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲市場分析、洞察與預測
    • 英國
    • 法國
    • 德國
    • 義大利
    • 俄羅斯
    • 其他歐洲國家
  • 亞太市場分析、洞察與預測
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 東南亞
    • 其他亞太國家
  • 拉丁美洲市場分析、洞察與預測
    • 巴西
    • 阿根廷
    • 秘魯
    • 智利
    • 其他拉丁美洲國家
  • 中東和非洲市場分析、洞察與預測
    • 沙烏地阿拉伯
    • UAE
    • 以色列
    • 南非
    • 其他中東和非洲國家

第9章 競爭情勢

  • 最新趨勢
  • 公司分類
  • 供應鏈和銷售管道合作夥伴（根據現有資訊）
  • 市場佔有率和市場定位分析（基於現有資訊）
  • 供應商情況（基於現有資訊）
  • 策略規劃

第10章：公司簡介

  • 主要公司的市佔率分析
  • 公司簡介
    • Lonza Group AG
    • Lubrizol Life Science
    • Cambrex Corporation
    • Contract Pharmaceuticals Limited
    • Bora Pharmaceuticals Co. Ltd
    • Ascendia Pharmaceuticals Inc
    • Pierre Fabre Group
    • Piramal Pharma Solutions
    • DPT Laboratories Ltd
    • MedPharm Ltd
    • Catalent Inc
    • Recipharm AB
    • Aenova Group GmbH
    • Almac Group Limited
簡介目錄
Product Code: VMR112118635

The global semi-solid dosage contract manufacturing market size is expected to reach USD 64.06 Billion in 2034 from USD 23.82 Billion in 2025, growing at a CAGR of 11.62 during 2026-2034.This market is witnessing healthy expansion as pharmaceutical companies increasingly outsource the production of creams, ointments, gels, lotions, and topical formulations to specialized manufacturing partners. Rising demand for dermatological products, pain management therapies, and cosmetic pharmaceuticals is encouraging greater reliance on contract manufacturing organizations. Cost optimization and faster product commercialization are also supporting market expansion.

Contract manufacturers are investing in advanced production facilities, automated filling systems, quality assurance technologies, and regulatory compliance to meet evolving pharmaceutical standards. Growing demand for customized formulations and specialized topical drug delivery systems is driving innovation across manufacturing processes. Strategic partnerships between pharmaceutical companies and contract manufacturers are improving production flexibility and operational efficiency.

Future growth is expected to be supported by increasing pharmaceutical outsourcing, expanding biologic-based topical therapies, and continuous investments in advanced manufacturing technologies. Digital quality management systems, automation, and sustainable production practices will improve manufacturing performance. Rising global demand for high-quality topical medicines will continue creating long-term opportunities for contract manufacturing providers.

Our reports are carefully developed to deliver comprehensive and actionable insights across a wide range of industries and markets. Each report includes several essential components designed to provide a complete understanding of the market environment:

Market Overview: This section provides a clear introduction to the market, including key definitions, classifications, and an overview of the current industry landscape.

Market Dynamics: A detailed evaluation of the primary drivers, restraints, opportunities, and challenges shaping market growth. It covers factors such as technological developments, regulatory frameworks, and evolving industry trends.

Segmentation Analysis: A structured breakdown of the market into key segments based on product type, application, end-user, and geographic region. This section highlights the performance, growth potential, and contribution of each segment.

Competitive Landscape: An in-depth assessment of leading market participants, including their market positioning, product portfolios, strategic initiatives, and financial performance. It provides valuable insights into competitive dynamics and the strategies adopted by key players.

Market Forecast: Data-driven projections of market size and growth patterns over a defined forecast period. This section incorporates historical trends, current market conditions, and quantitative analysis to illustrate expected future developments.

Regional Analysis: A comprehensive review of market performance across major geographic regions, identifying high-growth areas and regional trends to better understand localized market opportunities.

Emerging Trends and Opportunities: Identification of significant market trends, technological advancements, and new investment opportunities. This section highlights potential growth areas and future industry developments.

Customization Options: We offer flexible customization services to tailor reports according to specific client requirements. This may include additional segmentation, country-level analysis, competitor profiling, customized data points, or focused insights on particular market segments to better support strategic decision-making.

MARKET SEGMENTATION

By Type

  • Topical
  • Transdermal
  • Oral

By Product

  • Creams
  • Ointments
  • Gels
  • Lotions
  • Pastes
  • Others

By End Use

  • Pharmaceutical Companies
  • Cosmeceutical Companies
  • Others

By Company Size

  • Large Size Companies
  • Medium & Small Size Companies
  • Others

COMPANIES PROFILED

  • Lonza Group AG, Lubrizol Life Science, Cambrex Corporation, Contract Pharmaceuticals Limited, Bora Pharmaceuticals Co. Ltd., Ascendia Pharmaceuticals Inc., Pierre Fabre Group, Piramal Pharma Solutions, DPT Laboratories Ltd., MedPharm Ltd, Catalent Inc., Recipharm AB, Aenova Group GmbH, Almac Group Limited

TABLE OF CONTENTS

Chapter 1. PREFACE

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definition
  • 1.3. Information Procurement
    • 1.3.1 Information Analysis
    • 1.3.2 Market Formulation & Data Visualization
    • 1.3.3 Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

  • 2.1. Market Snapshot
  • 2.2. Segmental Outlook
  • 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

  • 3.1. Market Lineage Outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Value Chain Analysis
  • 3.4. Regulatory Framework
    • 3.4.1 Standards & Compliance
    • 3.4.2 Regulatory Impact Analysis
  • 3.5. Market Dynamics
    • 3.5.1 Market Drivers
    • 3.5.2 Market Restraints
    • 3.5.3 Market Opportunities
    • 3.5.4 Market Challenges
  • 3.6. Porter's Five Forces Analysis
  • 3.7. PESTLE Analysis

Chapter 4. GLOBAL SEMI-SOLID DOSAGE CONTRACT MANUFACTURING MARKET: BY TYPE 2022-2034 (USD MN)

  • 4.1. Market Analysis, Insights and Forecast Type
  • 4.2. Topical Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.3. Transdermal Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.4. Oral Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL SEMI-SOLID DOSAGE CONTRACT MANUFACTURING MARKET: BY PRODUCT 2022-2034 (USD MN)

  • 5.1. Market Analysis, Insights and Forecast Product
  • 5.2. Creams Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.3. Ointments Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.4. Gels Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.5. Lotions Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.6. Pastes Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.7. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL SEMI-SOLID DOSAGE CONTRACT MANUFACTURING MARKET: BY END USE 2022-2034 (USD MN)

  • 6.1. Market Analysis, Insights and Forecast End Use
  • 6.2. Pharmaceutical Companies Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.3. Cosmeceutical Companies Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.4. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL SEMI-SOLID DOSAGE CONTRACT MANUFACTURING MARKET: BY COMPANY SIZE 2022-2034 (USD MN)

  • 7.1. Market Analysis, Insights and Forecast Company Size
  • 7.2. Large Size Companies Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 7.3. Medium & Small Size Companies Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 7.4. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL SEMI-SOLID DOSAGE CONTRACT MANUFACTURING MARKET: BY REGION 2022-2034 (USD MN)

  • 8.1. Regional Outlook
  • 8.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 8.2.1 By Type
    • 8.2.2 By Product
    • 8.2.3 By End Use
    • 8.2.4 By Company Size
    • 8.2.5 United States
    • 8.2.6 Canada
    • 8.2.7 Mexico
  • 8.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 8.3.1 By Type
    • 8.3.2 By Product
    • 8.3.3 By End Use
    • 8.3.4 By Company Size
    • 8.3.5 United Kingdom
    • 8.3.6 France
    • 8.3.7 Germany
    • 8.3.8 Italy
    • 8.3.9 Russia
    • 8.3.10 Rest Of Europe
  • 8.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 8.4.1 By Type
    • 8.4.2 By Product
    • 8.4.3 By End Use
    • 8.4.4 By Company Size
    • 8.4.5 India
    • 8.4.6 Japan
    • 8.4.7 South Korea
    • 8.4.8 Australia
    • 8.4.9 South East Asia
    • 8.4.10 Rest Of Asia Pacific
  • 8.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 8.5.1 By Type
    • 8.5.2 By Product
    • 8.5.3 By End Use
    • 8.5.4 By Company Size
    • 8.5.5 Brazil
    • 8.5.6 Argentina
    • 8.5.7 Peru
    • 8.5.8 Chile
    • 8.5.9 Rest of Latin America
  • 8.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 8.6.1 By Type
    • 8.6.2 By Product
    • 8.6.3 By End Use
    • 8.6.4 By Company Size
    • 8.6.5 Saudi Arabia
    • 8.6.6 UAE
    • 8.6.7 Israel
    • 8.6.8 South Africa
    • 8.6.9 Rest of the Middle East And Africa

Chapter 9. COMPETITIVE LANDSCAPE

  • 9.1. Recent Developments
  • 9.2. Company Categorization
  • 9.3. Supply Chain & Channel Partners (based on availability)
  • 9.4. Market Share & Positioning Analysis (based on availability)
  • 9.5. Vendor Landscape (based on availability)
  • 9.6. Strategy Mapping

Chapter 10. COMPANY PROFILES OF GLOBAL SEMI-SOLID DOSAGE CONTRACT MANUFACTURING INDUSTRY

  • 10.1. Top Companies Market Share Analysis
  • 10.2. Company Profiles
    • 10.2.1 Lonza Group AG
    • 10.2.2 Lubrizol Life Science
    • 10.2.3 Cambrex Corporation
    • 10.2.4 Contract Pharmaceuticals Limited
    • 10.2.5 Bora Pharmaceuticals Co. Ltd
    • 10.2.6 Ascendia Pharmaceuticals Inc
    • 10.2.7 Pierre Fabre Group
    • 10.2.8 Piramal Pharma Solutions
    • 10.2.9 DPT Laboratories Ltd
    • 10.2.10 MedPharm Ltd
    • 10.2.11 Catalent Inc
    • 10.2.12 Recipharm AB
    • 10.2.13 Aenova Group GmbH
    • 10.2.14 Almac Group Limited